HCSGD entry for ACTA1
1. General information
Official gene symbol | ACTA1 |
---|---|
Entrez ID | 58 |
Gene full name | actin, alpha 1, skeletal muscle |
Other gene symbols | ACTA ASMA CFTD CFTD1 CFTDM MPFD NEM1 NEM2 NEM3 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0001725 | Stress fiber | IDA | cellular_component |
GO:0005200 | Structural constituent of cytoskeleton | TAS | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005524 | ATP binding | IEA TAS | molecular_function |
GO:0005737 | Cytoplasm | IEA | cellular_component |
GO:0005829 | Cytosol | TAS | cellular_component |
GO:0005856 | Cytoskeleton | IEA | cellular_component |
GO:0005865 | Striated muscle thin filament | IDA | cellular_component |
GO:0005884 | Actin filament | IDA | cellular_component |
GO:0006936 | Muscle contraction | TAS | biological_process |
GO:0009612 | Response to mechanical stimulus | IEA | biological_process |
GO:0009991 | Response to extracellular stimulus | IEA | biological_process |
GO:0010226 | Response to lithium ion | IEA | biological_process |
GO:0015629 | Actin cytoskeleton | IMP | cellular_component |
GO:0016049 | Cell growth | IEA | biological_process |
GO:0017022 | Myosin binding | TAS | molecular_function |
GO:0030017 | Sarcomere | IDA | cellular_component |
GO:0030049 | Muscle filament sliding | TAS | biological_process |
GO:0030240 | Skeletal muscle thin filament assembly | IMP | biological_process |
GO:0043503 | Skeletal muscle fiber adaptation | IEA | biological_process |
GO:0043531 | ADP binding | TAS | molecular_function |
GO:0048545 | Response to steroid hormone | IEA | biological_process |
GO:0048741 | Skeletal muscle fiber development | ISS | biological_process |
GO:0070062 | Extracellular vesicular exosome | IDA | cellular_component |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.9327944645 | 0.1518869686 | 0.9999902473 | 0.7523436771 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.5025461741 |
GSE13712_SHEAR | Up | 0.1923754187 |
GSE13712_STATIC | Down | -0.0852690195 |
GSE19018 | Down | -0.2590645054 |
GSE19899_A1 | Down | -0.2543383278 |
GSE19899_A2 | Up | 0.1554878985 |
PubMed_21979375_A1 | Down | -0.3463549671 |
PubMed_21979375_A2 | Down | -0.0637133105 |
GSE35957 | Down | -0.0046580346 |
GSE36640 | Up | 0.1565843972 |
GSE54402 | Down | -0.0938927251 |
GSE9593 | Up | 0.2605672460 |
GSE43922 | Down | -0.0155970183 |
GSE24585 | Down | -0.1135474614 |
GSE37065 | Down | -0.3262124523 |
GSE28863_A1 | Down | -0.0925309592 |
GSE28863_A2 | Down | -0.1252498461 |
GSE28863_A3 | Up | 0.2726713224 |
GSE28863_A4 | Down | -0.0445244369 |
GSE48662 | Down | -0.0269417935 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Latrunculin A | DB02621 | EXPT02004 |
Sucrose | DB02772 | EXPT02977 |
Ulapualide A | DB03021 | EXPT03182 |
Kabiramide C | DB03616 | EXPT01959 |
Jaspisamide A | DB03850 | EXPT01955 |
Tmr | DB03903 | EXPT02780 |
4-Methyl-Histidine | DB04151 | EXPT01748 |
Phosphoaminophosphonic Acid-Adenylate Ester | DB04395 | EXPT00524 |
Aplyronine A | DB04629 | - |
Reidispongiolide A | DB04774 | - |
Reidispongiolide C | DB04775 | - |
Sphinxolide B | DB04783 | - |
LATRUNCULIN B | DB08080 | - |
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-1 | MIMAT0000416 | MIRT023513 | Proteomics | Functional MTI (Weak) | 18668040 |
hsa-miR-877-5p | MIMAT0004949 | MIRT037359 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 6 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
26399448 | In this study, we show that primary cultures of fibroblasts derived from lung biopsies of IPF patients exhibited (i) accelerated replicative cellular senescence (CS); (ii) high resistance to oxidative-stress-induced cytotoxicity or CS; (iii) a CS-like morphology (even at the proliferative phase); and (iv) rapid accumulation of senescent cells expressing the myofibroblast marker alpha-SMA |
23719597 | In primary PSC, doxorubicin treatment was associated with increased expression of interleukin-6 (IL-6) and matrix metalloproteinase (MMP)-9, while expression of the activation marker alpha-smooth muscle actin (alpha-SMA), p53, Cdk1 and Rad54 was diminished |
23274627 | Comparison of TER, alpha-SMA and SA-beta-Gal between CAPD durations suggests that cell polarity weakens with increased duration of CAPD, reflecting the occurrence of EMT and cell senescence |
20720180 | Indoxyl sulfate inhibited serum-induced cell proliferation and promoted the activation of senescence-associated beta-galactosidase, a marker of cellular senescence, and the expression of alpha-smooth muscle actin (alpha-SMA), a marker of fibrosis, through inducing p53 expression and phosphorylation |
20720180 | Indoxyl sulfate evoked reactive oxygen species (ROS), and the antioxidant N-acetylcysteine inhibited indoxyl sulfate-induced p53 expression and phosphorylation, as well as indoxyl sulfate-induced alpha-SMA expression |
20585577 | The SCP cells produced CD24+ or ER+ luminal-like and ASMA+ myoepithelial-like progeny, in addition to CD44+ stem/progenitor-like cells |
11344338 | Exposure of the MK/T-1 cells to TGF-beta induces the expression of smooth muscle alpha-actin (ASMA), the activation of MAP Kinase (p38-MAPK) and morphological changes consistent with cytoskeletal reorganization |
Entries Per Page
Displaying Page of